ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 120 filers reported holding ANTARES PHARMA INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $99,000 | -59.1% | 30,000 | -62.5% | 0.00% | 0.0% |
| Q1 2019 | $242,000 | -31.6% | 80,000 | -38.5% | 0.00% | -50.0% |
| Q4 2018 | $354,000 | +31.6% | 130,000 | +62.5% | 0.00% | +100.0% |
| Q3 2018 | $269,000 | -19.7% | 80,000 | -38.5% | 0.00% | -50.0% |
| Q2 2018 | $335,000 | +17.1% | 130,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $286,000 | +10.4% | 130,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $259,000 | -38.5% | 130,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $421,000 | +0.5% | 130,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $419,000 | +84.6% | 130,000 | +62.5% | 0.00% | +100.0% |
| Q1 2017 | $227,000 | +845.8% | 80,000 | +607.3% | 0.00% | – |
| Q2 2015 | $24,000 | – | 11,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |